Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: To determine the clinical efficacy of recombinant human epidermal growth factor (rh-EGF) combined with povidone-iodine (PVI) on patients with pressure ulcers (PUs).
Methods: One hundred and five PU patients treated between January 2018 and January 2021 were enrolled and retrospectively analyzed. Of them, 50 patients who received conventional treatment were assigned to the control group (Con group), while 55 patients treated with rh-EGF combined with PVI were assigned to the observation group (Obs group). The two groups were compared in clinical efficacy, PU alleviation (total area reduction rate, total depth reduction rate, and total volume reduction rate), healing time, pain degree (Visual Analog Scale [VAS] score), inflammatory indexes (interleukin-8 [IL-8], tumor necrosis factor- [TNF-], and hypersensitive C reactive protein [hs-CRP]), and hydroxyproline content in the wound.
Results: The Obs group yielded a higher total effective rate than the Con group ( < 0.05). The Obs group also experienced statistically shorter healing time and milder pain, with better PU alleviation and lower levels of inflammation indexes compared with the Con group (all < 0.05). In addition, a higher hydroxyproline content in the wound was found in the Obs group.
Conclusions: All in all, rh-EGF combined with PVI has a definite curative effect on patients with PUs. It can promote PU alleviation and hydroxyproline secretion in the wound and inhibit pain and inflammatory reactions, which is worthy of clinical promotion.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436609 | PMC |
| http://dx.doi.org/10.1155/2022/3878320 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Silver Sulfadiazine and Recombinant Human Epidermal Growth Factor Treatment for Neonatal Extravasation: A Case Report.
Adv Neonatal Care
June 2025
Author Affiliations : National Key Clinical Specialty Construction Project/Neonatology Department, Guangdong Women and Children Hospital, Guangzhou, China (Ms Lin, Ms Huang, Dr Nie, Ms Zhou); and Neonatal Surgery Department, Guangdong Women and Children Hospital, Guangzhou, China (Ms Zhang).
Background: Neonates are at high risk of intravenous extravasation, which can cause severe tissue necrosis. However, few studies have combined silver sulfadiazine (SSD) with recombinant human epidermal growth factor (rh-EGF), which has limited application in neonatal patients, to treat extravasation. This report describes the case of a female neonate treated with SSD and rh-EGF for a skin injury caused by epinephrine extravasation.
View Article and Find Full Text PDFEfficacy of Human-Recombinant Epidermal Growth Factor Combined with Povidone-Iodine for Pressure Ulcers and Its Influence on Inflammatory Cytokines.
Mediators Inflamm
September 2022
Department of Burns and Plastic Surgery, Lu'an People's Hospital, Anhui Medical University, Lu'an, 237005 Anhui, China.
Purpose: To determine the clinical efficacy of recombinant human epidermal growth factor (rh-EGF) combined with povidone-iodine (PVI) on patients with pressure ulcers (PUs).
Methods: One hundred and five PU patients treated between January 2018 and January 2021 were enrolled and retrospectively analyzed. Of them, 50 patients who received conventional treatment were assigned to the control group (Con group), while 55 patients treated with rh-EGF combined with PVI were assigned to the observation group (Obs group).
Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats.
BMC Cardiovasc Disord
December 2018
Department of Cardiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, People's Republic of China.
Background: Our previous study showed that metformin regulates the mRNA and protein levels of type 2 small conductance calcium-activated potassium channel (SK2) and type 3 small conductance calcium-activated potassium channels (SK3) in atrial tissue as well as the ion current of atrial myocytes in rats with type 2 diabetes mellitus (T2DM), but the underlying signaling mechanism is unknown. This study aimed to investigate whether metformin regulates atrial SK2 and SK3 protein expression in T2DM rats though the protein kinase C (PKC)/extracellular signal-regulated kinase (ERK) signaling pathway.
Methods: A T2DM rat model was established using a high-fat and high-sugar diet combined with a low-dose intraperitoneal injection of streptozotocin (STZ).
Effect of recombinant human epidermal growth factor impregnated chitosan film on hemostasis and healing of blood vessels.
Arch Plast Surg
September 2014
Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Background: Bleeding can be a problem in wound debridement. In search for an effective hemostatic agent, we experimented with a chitosan film combined with the recombinant human epidermal growth factor (rh-EGF), hypothesizing that it would achieve effective hemostasis and simultaneously enhance arterial healing.
Methods: Forty-eight Sprague-Dawley rats were used, and 96 puncture wounds were made.
The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model.
Int Wound J
August 2014
Department of Plastic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Diabetic wound is a chronic wound in which normal process of wound healing is interrupted. Lack of blood supply, infection and lack of functional growth factors are assumed as some of the conditions that lead to non-healing environment. Epidermal growth factor (EGF) acts primarily to stimulate epithelial cell growth across wound.
View Article and Find Full Text PDF